Glibenclamide/metformin

Glibenclamide/metformin
Combination of
GlibenclamideSulfonylurea
MetforminBiguanide
Clinical data
Trade namesGlucovance
AHFS/Drugs.comMonograph
MedlinePlusa699055
License data
Pregnancy
category
Routes of
administration		By mouth
ATC code
  • None
Legal status
Legal status
Identifiers
CAS Number
KEGG

Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.[6] It contains glibenclamide, a sulfonylurea, and metformin, a biguanide.[7]

References

  1. ^ a b "TGA eBS - Product and Consumer Medicine Information Licence". Archived from the original on 23 March 2022. Retrieved 30 April 2022.
  2. ^ "Search the TGA website".
  3. ^ "Search the TGA website".
  4. ^ "Search the TGA website". Archived from the original on 30 April 2022. Retrieved 30 April 2022.
  5. ^ "Glucovance- glyburide and metformin hydrochloride tablet, film coated". DailyMed. 23 April 2012. Archived from the original on 30 April 2022. Retrieved 30 April 2022.
  6. ^ Lamos EM, Stein SA, Davis SN (December 2012). "Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus". Expert Opinion on Pharmacotherapy. 13 (17): 2545–54. doi:10.1517/14656566.2012.738196. PMID 23116560. S2CID 10305382.
  7. ^ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Archived from the original on 26 February 2021. Retrieved 11 August 2020.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.